GAS RELIEF  MINT FLAVOR- simethicone tablet, chewable 
Raritan Pharmaceuticals Inc

----------

DRxCHOICE Simethicone Gas Relief 36 Chewable Tablets

Active ingredient (in each tablet)

Simethicone 80 mg

Purpose

Antigas

Uses

Relieves:

Warnings

Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center immediately at 1-800-222-1222.

Directions

Other information

Inactive ingredients

dextrose, peppermint flavor, magnesium stearate, maltodextrin, microcrystalline cellulose, silica, tribasic calcium phosphate

Principal Display Panel

NDC 68163-111-36

DRx CHOICE

Gas Relief

Anti Gas/Simethicone 80 mg

For fast relief of Bloating, Pressure & Gas Distress

Mint Flavor

Naturally and Artificially Flavored

36 CHEWABLE TABLETS

Manufactured by: Raritan Pharmaceuticals

8 Joanna Court, East Brunswick, NJ 08816

DRx Choice Simethicone 36 Chewable Tablets
GAS RELIEF   MINT FLAVOR
simethicone tablet, chewable
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68163-111
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DIMETHICONE, UNSPECIFIED (UNII: 92RU3N3Y1O) (DIMETHICONE, UNSPECIFIED - UNII:92RU3N3Y1O) DIMETHICONE, UNSPECIFIED80 mg
Inactive Ingredients
Ingredient NameStrength
DEXTROSE, UNSPECIFIED FORM (UNII: IY9XDZ35W2)  
PEPPERMINT (UNII: V95R5KMY2B)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MALTODEXTRIN (UNII: 7CVR7L4A2D)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
TRICALCIUM PHOSPHATE (UNII: K4C08XP666)  
Product Characteristics
ColorwhiteScoreno score
ShapeROUNDSize13mm
FlavorPEPPERMINTImprint Code RP111
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:68163-111-3636 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product04/17/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00204/17/2019
Labeler - Raritan Pharmaceuticals Inc (127602287)

Revised: 9/2025
Document Id: 3fb19054-20ea-63fb-e063-6394a90aebe5
Set id: 329388cb-3ca1-4ecb-8b50-b1f9e0052559
Version: 7
Effective Time: 20250926
 
Raritan Pharmaceuticals Inc